Matches in Wikidata for { <http://www.wikidata.org/entity/Q91827922> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91827922 description "article scientifique publié en 2020" @default.
- Q91827922 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q91827922 description "scientific article published on 07 March 2020" @default.
- Q91827922 description "wetenschappelijk artikel" @default.
- Q91827922 description "наукова стаття, опублікована 7 березня 2020" @default.
- Q91827922 description "գիտական հոդված հրատարակված 2020 թվականի մարտի 7-ին" @default.
- Q91827922 name "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 name "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 type Item @default.
- Q91827922 label "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 label "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 prefLabel "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 prefLabel "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 P1433 Q91827922-493A32C6-1C88-4147-83D7-DC6067205E9D @default.
- Q91827922 P1476 Q91827922-408D3EA3-CAE7-4A53-9D7F-5D9C696755B2 @default.
- Q91827922 P2093 Q91827922-1CB7D9D1-6C0E-4FFB-B26A-56F8AC6BAA3A @default.
- Q91827922 P2093 Q91827922-4F363D65-1970-4F95-8DB8-39AC0B7737A5 @default.
- Q91827922 P2093 Q91827922-56D52EF4-FD7D-4DC3-8CA6-3FB4580917C1 @default.
- Q91827922 P2093 Q91827922-97806CDF-75BD-4E7D-B302-865E7415812A @default.
- Q91827922 P2093 Q91827922-BAEBF5E2-3622-4D3F-8B6F-B7D87BA2C471 @default.
- Q91827922 P2093 Q91827922-CE1EE870-78BA-4651-8CA4-4FE565A1D76D @default.
- Q91827922 P2093 Q91827922-DA3935C7-54D7-4AB7-BA1A-942C202C8D1F @default.
- Q91827922 P2093 Q91827922-DA9BA91C-A409-408B-83FE-744F587BF467 @default.
- Q91827922 P2093 Q91827922-E96D8D84-2624-480E-AE1F-48960F2C3041 @default.
- Q91827922 P2093 Q91827922-EB98B55E-915A-4A71-89F0-3265E29FDC88 @default.
- Q91827922 P31 Q91827922-FDDAD0E5-CEB1-4FF7-93A7-C6F01A542A03 @default.
- Q91827922 P356 Q91827922-800F81F9-58F4-4D6E-BAFD-32F6AB502C5D @default.
- Q91827922 P577 Q91827922-4C22B697-DC75-4FEF-AFF8-65798749E630 @default.
- Q91827922 P698 Q91827922-91DCF884-0D52-4DB0-93F8-F62EDC051CC3 @default.
- Q91827922 P356 J.CLML.2020.02.018 @default.
- Q91827922 P698 32278674 @default.
- Q91827922 P1433 Q5133774 @default.
- Q91827922 P1476 "Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies" @default.
- Q91827922 P2093 "Andrzej Jakubowiak" @default.
- Q91827922 P2093 "Annette Lam" @default.
- Q91827922 P2093 "Jesus San-Miguel" @default.
- Q91827922 P2093 "Jianming He" @default.
- Q91827922 P2093 "Maria-Victoria Mateos" @default.
- Q91827922 P2093 "Meletios A Dimopoulos" @default.
- Q91827922 P2093 "Michele Cavo" @default.
- Q91827922 P2093 "Ming Qi" @default.
- Q91827922 P2093 "Tobias Kampfenkel" @default.
- Q91827922 P2093 "William Deraedt" @default.
- Q91827922 P31 Q13442814 @default.
- Q91827922 P356 "10.1016/J.CLML.2020.02.018" @default.
- Q91827922 P577 "2020-03-07T00:00:00Z" @default.
- Q91827922 P698 "32278674" @default.